PHP
VCEL icon

Parkman Healthcare Partners’s Vericel Corp VCEL Stock Holding History

Parkman Healthcare Partners’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,340
Closed -$993K – 90
2021
Q3 		$993K Hold
20,340
– – 0.25% 65
2021
Q2 		$1.07M Sell
20,340
-89,660
-82% -$5.11M 0.23% 71
2021
Q1 		$6.11M Sell
110,000
-290,743
-73% -$13.2M 1.42% 25
2020
Q4 		$12.4M Sell
400,743
-49,657
-11% -$1.18M 3.17% 3
2020
Q3 		$8.35M Sell
450,400
-24,896
-5% -$412K 2.21% 12
2020
Q2 		$6.57M Buy
475,296
+145,000
+44% +$1.96M 1.85% 22
2020
Q1 		$3.03M Sell
330,296
-148,204
-31% -$2.22M 1.4% 28
2019
Q4 		$8.33M Buy
+478,500
New +$8.15M 2.4% 13

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Parkman Healthcare Partners's VCEL Position: Q4 2021 in Review

Parkman Healthcare Partners sold out of Vericel Corp (VCEL) in Q4 2021, closing a stake of 20,340 shares — an estimated $993K sold.

Parkman Healthcare Partners first reported a position in VCEL in Q4 2019 and held it in 8 quarters. The position peaked at $12.4M in Q4 2020. 185 funds tracked by Wall St. Rank hold VCEL as of Q4 2021.

  • Parkman Healthcare Partners reported no remaining Vericel Corp position as of Q4 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 20,340 Vericel Corp shares in Q4 2021, an estimated $993K.
  • Parkman Healthcare Partners first reported a position in Vericel Corp in Q4 2019 and held it in 8 quarters.
  • Parkman Healthcare Partners's Vericel Corp position peaked at $12.4M in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2021.

Based on Parkman Healthcare Partners's 13F filing for Q4 2021, filed 11 Feb 2022.